Literature DB >> 6948613

The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation.

V P Chuang, S Wallace, R S Benjamin, N Jaffe, A Ayala, J Murray, J Zornoza, Y Patt, G Mavligit, C Charnsangavej, C S Soo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6948613     DOI: 10.1007/bf02552525

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


× No keyword cloud information.
  22 in total

1.  Multidrug chemotherapy in pulmonary treatment of osteosarcoma.

Authors:  W W Sutow; E A Gehan; T J Vietti; A E Frias; P G Dyment
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

2.  Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies.

Authors:  W W Sutow; E A Gehan; P G Dyment; T Vietti; T Miale
Journal:  Cancer Treat Rep       Date:  1978-02

3.  Amputation and adriamycin in primary osteosarcoma: a 5-year report.

Authors:  E P Cortes; J F Holland; O Glidewell
Journal:  Cancer Treat Rep       Date:  1978-02

4.  Local en bloc resection for limb preservation.

Authors:  N Jaffe; H Watts; K E Fellows; G Vawter
Journal:  Cancer Treat Rep       Date:  1978-02

5.  Regression of regionally advanced melanoma after arterial infusion with cis-platinum and actinomycin-D.

Authors:  J D Pritchard; G M Mavligit; S Wallace; R S Benjamin; C M McBride
Journal:  Clin Oncol       Date:  1979-06

6.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Authors:  N Jaffe; E Frei; D Traggis; Y Bishop
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

7.  High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.

Authors:  G Rosen; S Suwansirikul; C Kwon; C Tan; S J Wu; E J Beattie; M L Murphy
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

8.  Cis-diamminedichloroplatinum (NSC-119875): a phase I study.

Authors:  D J Higby; H J Wallace; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

9.  cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.

Authors:  J J Ochs; A I Freeman; H O Douglass; D S Higby; E R Mindell; L F Sinks
Journal:  Cancer Treat Rep       Date:  1978-02

10.  Evaluation of response criteria in advanced lung cancer.

Authors:  R T Eagan; T R Fleming; V Schoonover
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

View more
  3 in total

1.  Limb-salvage procedures for osteosarcoma. An alternative to amputation.

Authors:  A C Wong; Y Akahoshi; S Takeuchi
Journal:  Int Orthop       Date:  1986       Impact factor: 3.075

Review 2.  Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective.

Authors:  Robert S Benjamin
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Osteosarcoma: evolution of treatment paradigms.

Authors:  Norman Jaffe; Ajay Puri; Hans Gelderblom
Journal:  Sarcoma       Date:  2013-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.